| Document Date: 2013-05-28 21:05:40
Open Document File Size: 113,32 KBShare Result on Facebook
City Ault / / Company Wiley-VCH Verlag GmbH & Co. KGaA / / Continent Africa / Asia / Europe / / Country Nepal / Bangladesh / Sudan / Kenya / Uganda / Brazil / Ethiopia / India / / Currency USD / / Event FDA Phase / / IndustryTerm defined products / potential tool / chemical entity / lymphatic and vascular systems / health systems / / MedicalCondition cured visceral leishmaniasis / HIV / granuloma / post-kala-azar dermal leishmaniasis / important infection / Europe’s neglected infections / bacterial and viral infections / leishmaniasis / Neuritis / clinical disease / lymphadenopathy / Author Trypanosomatid Diseases / malnutrition / abdominal pain / disease / neglected tropical diseases / malaria / Introduction Visceral leishmaniasis / treated visceral leishmaniasis / fever / Strategic Approaches Trypanosomatid Diseases / anthroponotic visceral leishmaniasis / primary visceral leishmaniasis / tumor necrosis factor / infectious diseases / HIV/AIDS / tropical diseases / infection / Visceral Leishmaniasis / Antimony-resistant Indian visceral leishmaniasis / established visceral leishmaniasis / tuberculosis / / MedicalTreatment immunotherapies / combination chemotherapy / immunotherapy / contraception / Immunosuppression / / Person Needs Poonam Salotra / Ruchi Singh / Karin Seifert / / Position candidate for this approach / Governor / / Product Paromomycin / dextrose / allopurinol / paromomycin sulfate / amphotericin B / ketoconazole / Daily / India / / ProvinceOrState S.K. / Bihar / West Bengal / Jharkhand / / Region East Africa / Southern Europe / Middle East / North Africa / Latin America / Caribbean / South Asia / / Technology Drug Discovery / chemotherapy / drug development / / URL www.dndi.org / www.clinicaltrials.gov / /
SocialTag |
j1 Part One Disease Burden, Current Treatments, Medical Needs, and Strategic Approaches